Sell IDBI on rally.. Remember the case of IOB. On october, after disappointing Q2 results, Dolat capital and some other advisors given a sell call on IOB with a target of 55/shr, when it was quoting around 74rs/share. then it rose to 94 in 3months with the market uptrend and then fallen sharply
10.31 PM Nov 5th
Rahul Jain, sector analyst, Dolat Capital Market Operating margins are way above consensus estimates. Volume growth of 7.3 per cent is the best in recent quarters. If the company says they`ll continue to report better volume growth in H2, the stock will react positively.
7.51 PM Oct 15th
a generic version of Nuedexta starting July 30, 2026, or earlier under certain circumstances. On Wednesday, the stock rose 9.3% over the previous close. Bhavin Shah, pharma analyst, Dolat Capital, said the Wockhardt management is doing everything possible to instill confidence among investors. Bhavika
12.46 PM Sep 12th
Please dont under estimate to AXIS...It is top 1 bank among the peers like hdfc & icici ============================== Axis-tgts-Angel Broking-1441-25.07.2013//Firstcall Research-1296-30.07.2013//Microsec-1458-25.07.2013//Dolat Capital-1450-22.07.2013//ICICI Direct-1445-22.07.2013//Sushil Finance
12.17 PM Sep 9th
Axis-tgts-Angel Broking-1441-25.07.2013//Firstcall Research-1296-30.07.2013//Microsec-1458-25.07.2013//Dolat Capital-1450-22.07.2013//ICICI Direct-1445-22.07.2013//Sushil Finance-1565-03.05.2013//AnandRathi-1635-27.04.2013//Sharekhan-1550-05.09.2013//Financial Times-2238-05.09.2013(consensus
10.08 PM Sep 8th
in the June quarter on the back of higher sales of antibiotic fidaxomicin, weight-loss drug Orlistat and higher generic insulin sales. Dolat Capital analysts believe that a ramp-up in sales of fidaxomicin antibiotic to Canada-based Optimer will add to the sales growth for the company. The company`s branded
2.22 PM Sep 6th
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.